Literature DB >> 301007

Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae.

R B Sykes, A Griffiths, D M Ryan.   

Abstract

On the basis of their susceptibility to ampicillin, strains of Haemophilus influenzae can be divided into three types: type 1 are normally susceptible strains, type 2 produce stable spheroplasts from low inocula, and type 3 are beta-lactamase producers. Because of the production of spheroplasts, standard broth and agar dilution techniques have failed to differentiate between the responses of type 2 and 3 strains to ampicillin, or to identify the superiority of cefuroxime over ampicillin against the beta-lactamase-producing strains. Disk susceptibility tests with heavily seeded plates were also difficult to interpret. To overcome these problems, we developed a medium that supports the growth of H. influenzae, but not survival of spheroplasts, thereby reducing the complicating influence of spheroplast formation. Utilization of the medium made it possible to identify beta-lactamase-producing strains via both minimal inhibitory concentration and disk susceptibility techniques, as well as the superiority of cefuroxime over ampicillin against such strains. In vivo experiments showed that cefuroxime and ampicillin are equally active against infections with type 1 and 2 strains, but that cefuroxime is superior to ampicillin against infections with type 3 beta-lactamase-producing strains.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301007      PMCID: PMC352035          DOI: 10.1128/AAC.11.4.599

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Ampicillin-resistant Haemophilus influenzae type B infection.

Authors:  M O Tomeh; S E Starr; J E McGowan; P M Terry; A J Nahmias
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

2.  Osmotically stable L forms of Haemophilus influenzae and their significance in testing sensitivity to penicillins.

Authors:  J R May; D E Roberts; A Ingold; S V Want
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

3.  Letter: Ampicillin-resistant haemophilus influenzae.

Authors:  B A Gunn; J B Woodall; J F Jones; C Thornsberry
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

4.  Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B.

Authors:  M S Schiffer; J MacLowry; R Schneerson; J B Robbins; J W McReynolds; W J Thomas; D W Bailey; E J Clarke; E J Mueller; J Escamilla
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

5.  Antimicrobial susceptibility of Hemophilus influenzae.

Authors:  S E McLinn; J D Nelson; K C Haltalin
Journal:  Pediatrics       Date:  1970-05       Impact factor: 7.124

6.  Letter: Chloramphenicol resistance in haemophilus species.

Authors:  P Cavanagh; C A Morris; N J Mitchell
Journal:  Lancet       Date:  1975-03-22       Impact factor: 79.321

7.  Chloramphenicol resistance in Haemophilus influenzae.

Authors:  A Manten; B van Klingeren; M Dessens-Kroon
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

8.  Beta-lactamase activity in ampicillin-resistant Haemophilus influenzae.

Authors:  W E Farrar; N M O'Dell
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

9.  Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin.

Authors:  A A Medeiros; T F O'Brien
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

10.  Sensitivity of Haemophilus influenzae to antibiotics.

Authors:  J D Williams; J Andrews
Journal:  Br Med J       Date:  1974-01-26
View more
  11 in total

Review 1.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

2.  Use and interpretation of Schlichter's test on Haemophilus influenzae: relation of in vitro to in vivo results for cefamandole.

Authors:  E Yourassowsky; M P van der Linden; E Schoutens
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

3.  Hemophilus influenzae pericarditis in two adults.

Authors:  S Weingarten; H Weinberg; M Fang; R D Meyer
Journal:  West J Med       Date:  1986-11

4.  Ampicillin killing curve patterns for ampicillin-susceptible nontypeable Haemophilus influenzae strains by the agar dilution plate count method.

Authors:  B F Woolfrey; M A Enright
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Growth curves, microscopic morphology, and subcultures of beta-lactamase-positive and -negative Haemophilus influenzae under the influence of ampicillin and cefamandole.

Authors:  E Yourassowsky; M P Van Der Linden; M J Lismont
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

Review 6.  Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

7.  Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study.

Authors:  M R Jacobs; S Bajaksouzian; A Zilles; G Lin; G A Pankuch; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

8.  Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae.

Authors:  Michael R Jacobs; Saralee Bajaksouzian; Anne Windau; Peter C Appelbaum; Gengrong Lin; David Felmingham; Christine Dencer; Laura Koeth; Mendel E Singer; Caryn E Good
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

10.  Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.

Authors:  R R Bulger; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.